Companies
BioMADE
expanded its biomanufacturing pilot-plant network with a new $40M Iowa facility (its third nationally) and finalized a $132M national-security-linked investment in a demonstration-scale facility in Minnesota.
- Country
- United States
US
Coverage
| EU | US | |
|---|---|---|
| automation-robotics | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Public-private partnership catalyzed by the U.S. Department of Defense and a member of Manufacturing USA | careers.biomade.org · biomade.org |
| Research focus | Bioindustrial manufacturing innovation, including scaling up production of chemicals, materials, agricultural bioproducts, and food products | careers.biomade.org · lucidodata.com · biomade.org |
| Facility | Pilot-scale biomanufacturing facility near Ames, Iowa; demonstration-scale biomanufacturing facility in Maple Grove, Minnesota | opportunityiowa.gov · biomade.org · startribune.com |
| Grant | $40M total investment for Iowa facility ($20M from BioMADE, $10M from ISU, $10M from IEDA); $132M total investment for Minnesota facility (funded by U.S. DoD and Minnesota DEED) | opportunityiowa.gov · biomade.org · startribune.com |
| Principal staff | Douglas Friedman (CEO), Jack Starr (Chief Manufacturing Officer), Melanie Tomczak (Chief Technology Officer & Head of Programs), Jill Zullo (EVP & COO) | biomade.org |
Independent sources: lucidodata.com · opportunityiowa.gov · startribune.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Scale-up centers for innovative biologic small-batch production | automation-robotics | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.